Form 8-K
8-K — Oncology Institute, Inc.
Accession: 0001079973-26-000721
Filed: 2026-05-22
Period: 2026-05-20
CIK: 0001799191
SIC: 8011 (SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE)
Item: <ITEMS>1.05
Item: Financial Statements and Exhibits
Documents
8-K — toi_8k.htm (Primary)
XML — IDEA: XBRL DOCUMENT (R1.htm)
XML — IDEA: XBRL DOCUMENT (R2.htm)
8-K — FORM 8-K
8-K (Primary)
Filename: toi_8k.htm · Sequence: 1
Current Report
false
0001799191
0001799191
2026-05-20
2026-05-20
0001799191
TOI:CommonStockParValue0.0001Member
2026-05-20
2026-05-20
0001799191
TOI:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockEachAtExercisePriceOf11.50PerShareMember
2026-05-20
2026-05-20
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________
Form 8-K
__________________________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported) May
20, 2026
___________________________________
THE ONCOLOGY INSTITUTE, INC.
(Exact name of registrant as specified in its charter)
___________________________________
Delaware
001-39248
84-3562323
(State or other jurisdiction
of incorporation)
(Commission File Number)
(I.R.S. Employer
Identification No.)
18000 Studebaker Road, Suite 800, Cerritos, CA
90703
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area
code: (562) 735-3226
(Former name or former address, if changed since last
report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written
communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement
communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement
communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b)
of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common stock, par value $0.0001
TOI
The Nasdaq Stock Market LLC
Redeemable warrants, each whole warrant exercisable for one share of Common stock, each at an exercise price of $11.50 per share
TOIIW
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an
emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange
Act of 1934 (17 CFR §240.12b-2).
Emerging growth company
¨
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ☐.
Item 1.05 Material Cybersecurity Incidents.
The Oncology Institute, Inc. (the “Company”) is providing
this disclosure, as a follow-up to its voluntary disclosure in Item 7.01 of a Current Report on Form 8-K filed on November 6, 2025, regarding
a cybersecurity incident affecting a software service provider (“Vendor”) utilized by the Company. At the time of the prior
voluntary disclosure, the Vendor had indicated that investigation was still ongoing and it could not yet confirm any evidence that any
patient personal information was compromised as a result of this incident. However, on May 20, 2026, Kroll, who is the third-party administrator
for the Vendor, notified the Company that the Vendor had detected unauthorized access by a third party to certain information systems
of the Company, including systems affecting data of patients. The Company believes that the cybersecurity incident has affected various
other healthcare service providers, and the Vendor has set up a patient portal through which it intends to provide information and responses
to inquiries.
Because of the Company’s technology security and continuity plan,
the Company worked swiftly in response, and its operations have continued in all material respects since the detection of the incident.
The Company remains committed to protecting the healthcare and other personal information of its patients and will work with the Vendor
to offer credit monitoring and protection to all impacted patients.
The Company is reserving all rights with respect to potential claims
against relevant third parties or service providers. Although the Company’s investigation and assessment remain ongoing, as of the
date of this filing, the Company believes that the incident has not had a material impact on the Company’s operations, financial
systems, or its quality of care to its patients, and the Company is currently evaluating any other material impact, if any, including
on its financial condition or results of operations.
Cautionary Statement Regarding Forward-Looking Statements
This Current Report on Form 8-K contains statements about future events
and expectations which are “forward-looking statements” within the meaning of Sections 27A of the Securities Act of 1933,
as amended, and 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements can be identified by forward-looking
words such as “may,” “might,” “could,” “would,” “should,” “will,”
“anticipate,” “believe,” “plan,” “estimate,” “project,” “expect,”
“intend,” “seek,” “are encouraged,” and other similar expressions. Any statement contained in this
Current Report on Form 8-K that is not a statement of historical fact may be deemed to be a forward-looking statement. All forward-looking
statements involve risks, uncertainties and other factors that may cause actual results to differ materially from those expressed or implied
in the forward-looking statements. For example, all statements regarding the impact of the incident described above on the Company and
its operations, financial systems, or its financial condition, the scope of the investigation, expectations regarding the adequacy of
insurance, the Company’s plans, objectives, projections and expectations regarding the Company’s operations or financial condition,
and assumptions related thereto are all forward-looking statements. Factors that might cause the Company’s actual results to differ
materially from those anticipated in forward-looking statements include, but are not limited to, the Company’s ongoing assessment
of the impacts of the cybersecurity incident, including the Company’s potential discovery of additional information related to the
incident in connection with its investigation or otherwise; the Company’s expectations regarding its ability to contain and
remediate the cybersecurity incident; the impact of the cybersecurity incident on the Company’s relationships with patients,
employees, and governmental regulators; the legal, reputational, and financial risks resulting from the cybersecurity incident, including
as may arise from any exfiltrated data or any potential regulatory inquiries and/or litigation to which the Company may become subject
in connection with the incident; any further or still undetected cyber security incident; and remediation and other additional
costs that may be incurred by the Company in connection with the investigation and remediation of the incident. The forward-looking statements
speak only as of the date of this Current Report on Form 8-K. The Company undertakes no obligation to publicly update or revise any forward-looking
statements, whether as a result of new information, future events, or otherwise, except as required by applicable law.
Item 9.01.
Financial Statements and Exhibits.
(d)
Exhibits
Exhibit
No.
Description
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: May 22, 2026
THE ONCOLOGY INSTITUTE, INC.
By:
/s/ Minh Merchant
Name:
Minh Merchant
Title:
Chief Legal Officer
XML — IDEA: XBRL DOCUMENT
XML
Filename: R1.htm · Sequence: 7
v3.26.1
Cover
May 20, 2026
Document Type
8-K
Amendment Flag
false
Document Period End Date
May 20, 2026
Entity File Number
001-39248
Entity Registrant Name
THE ONCOLOGY INSTITUTE, INC.
Entity Central Index Key
0001799191
Entity Tax Identification Number
84-3562323
Entity Incorporation, State or Country Code
DE
Entity Address, Address Line One
18000 Studebaker Road
Entity Address, Address Line Two
Suite 800
Entity Address, City or Town
Cerritos
Entity Address, State or Province
CA
Entity Address, Postal Zip Code
90703
City Area Code
(562)
Local Phone Number
735-3226
Written Communications
false
Soliciting Material
false
Pre-commencement Tender Offer
false
Pre-commencement Issuer Tender Offer
false
Entity Emerging Growth Company
false
Common Stock, par value $0.0001
Title of 12(b) Security
Common stock, par value $0.0001
Trading Symbol
TOI
Security Exchange Name
NASDAQ
Redeemable Warrants, each whole warrant exercisable for one share of common stock, each at an exercise price of $11.50 per share
Title of 12(b) Security
Redeemable warrants, each whole warrant exercisable for one share of Common stock, each at an exercise price of $11.50 per share
Trading Symbol
TOIIW
Security Exchange Name
NASDAQ
X
- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details
Name:
dei_AmendmentFlag
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Area code of city
+ References
No definition available.
+ Details
Name:
dei_CityAreaCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details
Name:
dei_DocumentPeriodEndDate
Namespace Prefix:
dei_
Data Type:
xbrli:dateItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details
Name:
dei_DocumentType
Namespace Prefix:
dei_
Data Type:
dei:submissionTypeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine1
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 2 such as Street or Suite number
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine2
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the City or Town
+ References
No definition available.
+ Details
Name:
dei_EntityAddressCityOrTown
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details
Name:
dei_EntityAddressPostalZipCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the state or province.
+ References
No definition available.
+ Details
Name:
dei_EntityAddressStateOrProvince
Namespace Prefix:
dei_
Data Type:
dei:stateOrProvinceItemType
Balance Type:
na
Period Type:
duration
X
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityCentralIndexKey
Namespace Prefix:
dei_
Data Type:
dei:centralIndexKeyItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityEmergingGrowthCompany
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details
Name:
dei_EntityFileNumber
Namespace Prefix:
dei_
Data Type:
dei:fileNumberItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details
Name:
dei_EntityIncorporationStateCountryCode
Namespace Prefix:
dei_
Data Type:
dei:edgarStateCountryItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityRegistrantName
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityTaxIdentificationNumber
Namespace Prefix:
dei_
Data Type:
dei:employerIdItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Local phone number for entity.
+ References
No definition available.
+ Details
Name:
dei_LocalPhoneNumber
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details
Name:
dei_PreCommencementIssuerTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details
Name:
dei_PreCommencementTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details
Name:
dei_Security12bTitle
Namespace Prefix:
dei_
Data Type:
dei:securityTitleItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details
Name:
dei_SecurityExchangeName
Namespace Prefix:
dei_
Data Type:
dei:edgarExchangeCodeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14a
-Subsection 12
+ Details
Name:
dei_SolicitingMaterial
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details
Name:
dei_TradingSymbol
Namespace Prefix:
dei_
Data Type:
dei:tradingSymbolItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details
Name:
dei_WrittenCommunications
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Details
Name:
us-gaap_StatementClassOfStockAxis=TOI_CommonStockParValue0.0001Member
Namespace Prefix:
Data Type:
na
Balance Type:
Period Type:
X
- Details
Name:
us-gaap_StatementClassOfStockAxis=TOI_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockEachAtExercisePriceOf11.50PerShareMember
Namespace Prefix:
Data Type:
na
Balance Type:
Period Type:
XML — IDEA: XBRL DOCUMENT
XML
Filename: R2.htm · Sequence: 8
v3.26.1
Material Cybersecurity Incident Disclosure
May 20, 2026
Material Cybersecurity Incident [Abstract]
Material Cybersecurity Incident Nature [Text Block]
on November 6, 2025, regarding
a cybersecurity incident affecting a software service provider (“Vendor”) utilized by the Company. At the time of the prior
voluntary disclosure, the Vendor had indicated that investigation was still ongoing and it could not yet confirm any evidence that any
patient personal information was compromised as a result of this incident.
Material Cybersecurity Incident Scope [Text Block]
However, on May 20, 2026, Kroll, who is the third-party administrator
for the Vendor, notified the Company that the Vendor had detected unauthorized access by a third party to certain information systems
of the Company, including systems affecting data of patients. The Company believes that the cybersecurity incident has affected various
other healthcare service providers, and the Vendor has set up a patient portal through which it intends to provide information and responses
to inquiries.
Material Cybersecurity Incident Timing [Text Block]
Because of the Company’s technology security and continuity plan,
the Company worked swiftly in response, and its operations have continued in all material respects since the detection of the incident.
The Company remains committed to protecting the healthcare and other personal information of its patients and will work with the Vendor
to offer credit monitoring and protection to all impacted patients.
Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]
The Company is reserving all rights with respect to potential claims
against relevant third parties or service providers. Although the Company’s investigation and assessment remain ongoing, as of the
date of this filing, the Company believes that the incident has not had a material impact on the Company’s operations, financial
systems, or its quality of care to its patients, and the Company is currently evaluating any other material impact, if any, including
on its financial condition or results of operations.
Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]
on May 20, 2026, Kroll, who is the third-party administrator
for the Vendor, notified the Company that the Vendor had detected unauthorized access by a third party to certain information systems
of the Company, including systems affecting data of patients.
X
- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form 8-K
-Section 1.05
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form 6-K
-Section General Instruction
-Subsection B
+ Details
Name:
cyd_MaterialCybersecurityIncidentAbstract
Namespace Prefix:
cyd_
Data Type:
i:stringItemType
Balance Type:
na
Period Type:
duration
X
- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form 8-K
-Section 1.05
-Subsection Instruction
-Paragraph 2
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form 6-K
-Section General Instruction
-Subsection B
+ Details
Name:
cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock
Namespace Prefix:
cyd_
Data Type:
dtr-types:textBlockItemType
Balance Type:
na
Period Type:
duration
X
- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form 8-K
-Section 1.05
-Subsection a
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form 6-K
-Section General Instruction
-Subsection B
+ Details
Name:
cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock
Namespace Prefix:
cyd_
Data Type:
dtr-types:textBlockItemType
Balance Type:
na
Period Type:
duration
X
- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form 8-K
-Section 1.05
-Subsection a
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form 6-K
-Section General Instruction
-Subsection B
+ Details
Name:
cyd_MaterialCybersecurityIncidentNatureTextBlock
Namespace Prefix:
cyd_
Data Type:
dtr-types:textBlockItemType
Balance Type:
na
Period Type:
duration
X
- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form 8-K
-Section 1.05
-Subsection a
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form 6-K
-Section General Instruction
-Subsection B
+ Details
Name:
cyd_MaterialCybersecurityIncidentScopeTextBlock
Namespace Prefix:
cyd_
Data Type:
dtr-types:textBlockItemType
Balance Type:
na
Period Type:
duration
X
- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form 8-K
-Section 1.05
-Subsection a
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form 6-K
-Section General Instruction
-Subsection B
+ Details
Name:
cyd_MaterialCybersecurityIncidentTimingTextBlock
Namespace Prefix:
cyd_
Data Type:
dtr-types:textBlockItemType
Balance Type:
na
Period Type:
duration